Table 3.
Clinical and bite characteristics among pediatric patients, stratified by age.
| 0–6 years (n = 32) | 7–12 years (n = 32) | 13–17 years (n = 30) | |
|---|---|---|---|
| Female | 11 (34%) | 16 (50%) | 9 (30%) |
| Upper extremity bites | 4 (12.5%) | 10 (31%) | 10 (33%) |
| Hematologic toxicity | 17 (53.1%) | 18 (56%) | 18 (60%) |
| Edema | 29 (90.6%) | 27 (84%) | 26 (87%) |
| Ecchymosis | 25 (78.1%) | 24 (75%) | 19 (63%) |
| Necrosis | 1 (3%) | 2 (6%) | 0 (0%) |
| Number of vials for initial control* | 5 (4–5) | 5 (4–6) | 4 (4–6) |
| Total number of vials* | 10 (6–18) | 13 (8–16) | 10 (8–16) |
| Length of stay in days* | 2 (1–3) | 2 (1–2) | 2 (1–2) |
| Late hematologic toxicity† | 8 (25%) | 3 (9%) | 7 (23%) |
| Recurrence | 7 (21.9%) | 3 (9%) | 2 (6.7%) |
| Delayed toxicity | 1 (3.12%) | 0 (0%) | 5 (16.6%) |
Values are presented as whole number and percent, unless otherwise specified
*Values represent median and interquartile range
†Number of recurrent cases plus delayed toxicity does not add to number of late hematologic toxicity as some patients had both recurrence and late toxicity (e.g., recurrent coagulopathy but late thrombocytopenia)